Experience

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Hologic, Inc. of $950 million aggregate principal amount of its…

Davis Polk advised the underwriters in connection with an offering by Kemper Corporation of $400 million aggregate principal amount of its 2.400% senior notes due 2030. Kemper…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of €6.25 billion aggregate principal amount of notes by Medtronic Global…

We advised the joint lead arrangers and bookrunners on the amendment

Davis Polk advised Kingsoft Cloud Holdings Limited and certain selling shareholders on its approximately $509 million SEC-registered follow-on public offering of 16,421,576 American…

 Davis Polk advised ADC Therapeutics SA on its SEC-registered offering of 6,000,000 common shares for total gross proceeds of $204 million. ADC Therapeutics is listed on the New York…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of $500 million aggregate principal amount of its floating-rate senior notes due 2023, under its medium-term…

Davis Polk advised Zai Lab Limited in connection with its secondary listing and initial public offering on the Hong Kong Stock Exchange. Zai Lab is the first company listed under both…

Davis Polk advised the lead manager, sole book-runner and representative of the several underwriters in connection with an SEC-registered offering by Bank of America Corporation…

Davis Polk advised NatWest Group plc in connection with its cash tender offer for any and all of certain series of its outstanding bank capital securities.NatWest Group is the holding…